* Delcath Systems Inc DCTH.OQ reported a quarterly
adjusted loss
of 45 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -77 cents. The mean expectation of five analysts for the
quarter was for a loss of 47 cents per share. Wall Street
expected results to range from -61 cents to -37 cents per share.
* Revenue rose 425.8% to $3.14 million from a year ago;
analysts
expected $2.19 million.
* Delcath Systems Inc's reported EPS for the quarter was a
loss
of 45 cents.
* The company reported a quarterly loss of $11.11 million.
* Delcath Systems Inc shares had risen by 13.2% this
quarter and
gained 29.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Delcath Systems
Inc is $20.00
This summary was machine generated from LSEG data May 14 at
02:25 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.47 -0.45 Beat
Dec. 31 2023 -0.51 -0.48 Beat
Sep. 30 2023 -0.52 -1.14 Missed
Jun. 30 2023 -0.60 -0.67 Missed